BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Angel Broking Recommends 'Buy' On Alkem Laboratories
Angel Broking sees strong growth in Alkem Laboratories' domestic business due to its leadership in the acute therapeutic segment. Alkem expects to launch more products in USA, which bodes well for its international business, the brokerage adds.